PDGF-BB Regulates p27 Expression through ERK-dependent RNA Turn-over inVascular Smooth MuscleCells
Open Access
- 1 July 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (27) , 25470-25477
- https://doi.org/10.1074/jbc.m502320200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Inhibition of Vascular Smooth Muscle Cell Proliferation and Neointimal Formation in Injured Arteries by a Novel, Oral Mitogen-Activated Protein Kinase/Extracellular Signal–Regulated Kinase InhibitorCirculation, 2004
- Role of JNK, p38, and ERK in Platelet-Derived Growth Factor–Induced Vascular Proliferation, Migration, and Gene ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypesJournal of Cellular Biochemistry, 2003
- Cell Attachment to the Extracellular Matrix Induces Proteasomal Degradation of p21CIP1 via Cdc42/Rac1 SignalingMolecular and Cellular Biology, 2002
- Rho Activity Can Alter the Translation of p27 mRNA and Is Important for RasV12-induced Transformation in a Manner Dependent on p27 StatusJournal of Biological Chemistry, 2002
- The p42/p44 Mitogen-activated Protein Kinase Activation Triggers p27Kip1 Degradation Independently of CDK2/Cyclin E in NIH 3T3 CellsJournal of Biological Chemistry, 2001
- A U-Rich Element in the 5′ Untranslated Region Is Necessary for the Translation of p27 mRNAMolecular and Cellular Biology, 2000
- Differential Regulation of P27Kip1 Expression by Mitogenic and Hypertrophic FactorsThe Journal of cell biology, 2000
- Ribosomal S6 Kinase Signaling and the Control of TranslationExperimental Cell Research, 1999
- A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II–stimulated vascular smooth muscle cell hypertrophyJournal of Clinical Investigation, 1999